The metabolic syndrome (MetS) induces intrarenal microvascular disease, which may involve mitochondrial injury. The mitochondrial cardiolipin-targeting peptide elamipretide (ELAM) improves the microcirculation in post-stenotic kidneys, but its ability to attenuate MetS-induced renal vascular damage is unknown. We hypothesized that chronic treatment with ELAM would decrease renal vascular remodelling and function in swine MetS. Pigs were studied after 16 weeks of diet-induced MetS, MetS treated for the last 4 weeks with daily injections of ELAM (0.1 mg kg −1 ), and lean control (Lean) animals (n = 6 each). Single-kidney regional perfusion, blood flow and glomerular filtration rate were measured with multi-detector computed tomography (CT).
INTRODUCTION
The metabolic syndrome (MetS) is defined as a constellation of major cardiovascular risk factors, including obesity, hypertension, dyslipidaemia and insulin resistance, that reflect overnutrition and sedentary lifestyles. The prevalence of the MetS is increasing to epidemic proportions (Cameron, Shaw, & Zimmet, 2004) , increasing a person's risk of cardiovascular disease, stroke and all-cause mortality (Ferraro et al., 2011; Martins, Ani, Pan, Ogunyemi, & Norris, 2010) . The MetS has also been associated with the development and progression of chronic kidney disease (CKD; Thomas et al., 2011) , partly because c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society diabetes and hypertension remain the primary causes of CKD and endstage renal disease (Saran et al., 2017) .
The renal circulation is a structural and functional network composed of large vessels (e.g. renal arteries) that progressively branch into medium-sized and small microvessels, glomerular capillaries and, finally, peritubular capillaries (PTCs) that surround renal tubules to ensure tissue perfusion and remove unwanted substances from the filtrate (Chade & Hall, 2016) . We have previously shown that MetS in Ossabaw pigs is associated with renal microvascular remodelling and immaturity (Li et al., 2011) . We have also shown that the number of cortical microvessels and PTC density
New Findings

• What is the central question of this study?
We hypothesized that chronic mitoprotection would decrease renal vascular remodelling and dysfunction in swine metabolic syndrome.
• What is the main finding and its importance?
This study shows that experimental metabolic syndrome exerts renal microvascular and endothelial cell mitochondrial injury, which were attenuated by mitoprotection, underscoring the contribution of mitochondrial injury to the pathogenesis of metabolic syndrome-induced vascular damage.
were diminished in domestic pigs with diet-induced MetS, indicating microvascular loss . Importantly, microvascular remodelling and loss are known contributors to the progression of renal injury (Anderson et al., 2009 ). However, the exact mechanisms of MetS-induced renal vascular damage remain to be elucidated fully.
Unlike tubular cells that are rich in mitochondria, the mitochondrial content in endothelial cells (ECs) is relatively modest (Caja & Enriquez, 2017) . Nevertheless, these mitochondria might be important because renal ECs regulate vascular function, partly by modulating cell death, oxidative stress and nitric oxide (NO) bioavailability (Kluge, Fetterman, & Vita, 2013) . For example, increased oxidative stress in renal EC mitochondria induces p53, promoting translocation of the proapoptotic Bax (Cheng, Cui, Chen, & Du, 2007) , and generation of mitochondrial reactive oxygen species inhibits anti-apoptotic factors, such as B-cell lymphoma 2 (BCL2), leading to apoptosis (Green & Reed, 1998) . Furthermore, an excess of mitochondrial reactive oxygen species activates cellular NADPH oxidase and the subsequent formation of superoxide. This, in turn, interacts with NO, forming peroxinitrate, which damages the respiratory complexes I and III, diminishing NO bioavailability and creating a vicious cycle of oxidative stress, mitochondrial injury and endothelial dysfunction (Doughan, Harrison, & Dikalov, 2008) . Therefore, treatment strategies that preserve the morphology and function of EC mitochondria might ameliorate MetS-induced renal vascular damage.
Mitochondria-targeted peptides are small compounds that specifically target mitochondrial pathways. Elamipretide (ELAM) is a small synthetic tetrapeptide that is concentrated in the mitochondrion, specifically binding and stabilizing cardiolipin, an essential constituent of the inner mitochondrial membrane implicated in the formation of cristae membranes and energy production (Szeto, 2005) . Cardiolipin possesses a unique conical shape that favours the formation of cristae in the inner membrane (Szeto, 2014) and interacts with inner membrane proteins, contributing to the formation of supercomplexes that enhance energy production. Cardiolipin also interacts with cytochrome c, potentiating its role as an electron carrier, and its preservation with ELAM prevents cytochrome c peroxidase activity, ameliorating oxidative stress (Birk, Chao, Bracken, Warren, & Szeto, 2014) . Elamipretide also prevents formation of the mitochondrial permeability transition pore, and the subsequent release of cytochrome c to the cytosol to initiate apoptosis. Importantly, mitochondrial uptake of ELAM is independent of membrane potential, as opposed to some other mitochondria-targeted antioxidants (e.g. mito-tempo, mito-Q; Zhao et al., 2004) . Therefore, ELAM potentiates electron transport chain activity and exerts important antioxidant and anti-apoptotic effects that can protect ECs. We have previously shown in swine with renal artery stenosis that treatment with ELAM preserved the renal microcirculation in the post-stenotic kidney (Eirin et al., 2012b , but whether this approach preserves the renal vasculature in MetS has not been explored. Therefore, in this study we tested the hypothesis that chronic treatment with ELAM would decrease renal vascular remodelling and function in swine MetS.
METHODS
Ethical approval
All animal experiments were performed with the approval of the institutional animal care and use committee (#A3291-01) and conform to the principles and regulations, as described by Grundy (2015) . haemodynamics and function were assessed using multi-detector computed tomography (MDCT), and mean arterial pressure was assessed using an arterial catheter inserted in the left carotid artery, as previously described (Krier et al., 2001) .
Animal characteristics and experimental protocol
Fasting blood samples were collected before MDCT studies to assess plasma renin activity, and concentrations of creatinine (Eirin et al., 2011) , total cholesterol, low-density lipoprotein and triglyceride, and glucose and insulin concentrations for calculation of the homeostasis model assessment of insulin resistance (HOMA-IR; Li et al., 2014; Pawar et al., 2015; Zhang et al., 2013) .
One week later, animals were killed with a lethal bolus of 100 mg kg −1 of sodium pentobarbital (Fatal Plus, Vortech Pharmaceuticals, Deaborn, MI, USA) administered via the ear vein (Khangura et al., 2014) . The kidneys were removed using a retroperitoneal incision and immediately dissected. A segment of the kidney was prepared for micro-computed tomography (micro-CT) studies, and the remaining kidney tissue frozen in liquid nitrogen or preserved in formalin or Trump's fixative for ex vivo studies. Distal branches of the renal artery were dissected and placed in Krebs solution for in vitro endothelial function studies.
2.2.1
In vivo studies
The MDCT scanning was performed using a 128 scanner (128-Slice Somatom Definition Flash; Siemens Medical Solutions, Forchheim, Germany), an ultrafast scanner that provides noninvasive quantifications of single-kidney regional perfusion and renal blood flow (RBF; Eirin et al., 2012a; Krier et al., 2001) . In brief, an
Iohexol bolus [0.5 ml kg −1 (2 s) −1 , Omnipaque, GE Healthcare, Inc.
Marlborough, MA, USA] was injected 2 s after initiation of scanning.
Image acquisition consisted of 70 scans that cycled every 0.57 s, followed by 70 scans with a 2 s cycle, resulting in 140 sequential images collected over 3 min (Daghini et al., 2007b) Cross-sectional MDCT images were reconstructed, analysed using Analyze TM (Biomedical Imaging Resource, Mayo Clinic, MN, USA), and renal cortical and medullary perfusion and RBF were calculated, as previously described (Eirin et al., 2012a; Krier et al., 2001) . Briefly, regions of interest were selected from the aorta, renal cortex and medulla ( Figure 1 ), and tissue time-attenuation curves were analysed using a modified -variable model (Daghini et al., 2007b ) that yielded curve-fitting algorithms to measure cortical and medullary perfusion.
Cortical and medullary volumes were calculated using the planimetry method, whereas RBF was computed as the sum of the products of cortical and medullary perfusions and volumes, and GFR was calculated from the cortical proximal-tubular curve (Daghini et al., 2007a ).
Ex vivo studies
Peritubular capillary endothelial cell mitochondrial morphology and cardiolipin content
Mitochondrial density and morphology were assessed in randomly selected PTC-ECs (five per pig; a total of 30 per group), using a digital electron microscopy (Philips CM10). The number of mitochondria per cell was averaged to obtain mitochondrial number, and mitochondrial area and matrix density measured using Image-J software (Parra et al., 2014; Szeto, Liu, Soong, & Birk, 2015) . The number of PTCs was quantified in a blinded fashion in sections stained with Haematoxylin and Eosin, as previously described (Eirin et al., 2012b 
Renal microvascular architecture
Under physiological pressure, one kidney from each pig was perfused with a radio-opaque silicone polymer (Microfil MV122; Flow Tech, Carver, MA, USA), using a saline-filled cannula (PE 190 ) and a syringe infusion pump (SIP 22; Harvard Apparatus, Holliston, MA, USA) until the polymer drained freely from a segmental vein. Perfused sections were preserved in 10% buffered formalin, then scanned using a micro-CT scanner, which generates three-dimensional images consisting of up to a billion cubic voxels, each 5-25 m on a side, with isotropic spatial resolution. Images were reconstructed (20 m voxels), and the spatial density of cortical and medullary microvessels (diameters F I G U R E 1 Representative cross-sectional multi-detector computed tomography image of the kidney showing aortic (red), cortical (blue) and medullary (yellow) regions of interest 20-500 m) was calculated using Analyze TM , as previously described (Favreau et al., 2010; Zhu et al., 2004) . Vessel tortuosity was assessed by the 'connectivity index' (vessel length divided by the shortest distance between its ends; Bentley et al., 2002) . In addition, the mediato-lumen ratio was calculated in randomly selected intrarenal vessels in -smooth muscle actin (SMA)-stained sections (DakoCytomation A/S, Glostrup, Denmark).
Renal inflammation and fibrosis
Before MDCT scans and under fluoroscopic guidance, catheters were advanced into the renal vein and blood samples collected, centrifuged, and plasma aliquots stored at −80 • C. Renal vein levels of interleukin (IL)-1 , tumour necrosis factor-(TNF-) and IL-6 were measured by luminex (Millipore, Billerica, MA, USA; Yuan et al., 2018) . Additionally, renal fibrosis was assessed in renal cross-sections stained with trichrome, which was quantified semi-automatically in 15-20 fields in a blinded manner.
Renal vascular endothelial function
Dissected renal artery sections (2-3 mm long, one per animal) were suspended in 25 ml organ chambers (one per renal artery ring) filled with Krebs solution at 37 • C (pH 7.4, 95% O 2 -5% CO 2 ). Isometric force was measured by suspending the renal artery sections using two stainless-clips passed through the lumen and attached to a stationary post and a strain gauge. Vessels were allowed to equilibrate for 30 min after washing with control solution. After precontraction with endothelin-1 (10 −7 M; Phoenix Pharmaceuticals, Mountain
View, CA, USA), increasing concentrations of ACh (from 10 −9 to 10 −4 M) were added to the bath to evaluate endothelium-dependent relaxation, or increasing concentrations of sodium nitroprusside (SNP; from 10 −9 to 10 −4 M) were added to evaluate endotheliumindependent-vasodilatation. Data were quantified using WinDaq Acquisition Software (DATAQ Instruments, Inc. Akron, OH, USA).
In addition, cardiolipin staining, endothelial nitric oxide synthase (eNOS) expression and apoptosis (TUNEL) were assessed in these renal artery sections, as was production of superoxide anion by dihydroethidium (DHE) staining.
Statistical analysis
All data were analysed using JMP Pro 13 (SAS Institute Inc., Cary, NC, USA). The Shapiro-Wilk test was used to assess the normality of distribution of the tested variables. Normally distributed variables were expressed as means ± SD and compared with one-way ANOVA 
RESULTS
After 16 weeks of diet, body weight was higher in MetS and
MetS+ELAM compared with Lean pigs (91.8 ± 2.1 and 91.3 ± 4.5 versus 72.3 ± 11.1 kg, respectively, both P < 0.05), and lipid fractions were higher in both MetS groups ( Triglycerides (mg dl −1 ) 7.4 ± 1.7 7.4 ± 1.5 17.9 ± 7.8* 16.1 ± 5.8* Plasma renin activity (ng ml −1 h −1 ) 0.17 ± 0.11 0.15 ± 0.11 0.16 ± 0.07 0.14 ± 0.08
Serum creatinine (mg dl −1 ) 1.7 ± 0.2 1.6 ± 0.4 1.6 ± 0.2 1.8 ± 0.3
Renal volume (ml min −1 ) 137.6 ± 18.5 145.5 ± 8.9 223.0 ± 21.3* 236.4 ± 25.5* Cortical perfusion (ml min −1 cm −2 ) 3.9 ± 0.8 3.8 ± 0.6 4.1 ± 0.5 4.0 ± 0.8
Medullary perfusion (ml min −1 cm −2 ) 3.4 (2.0-3.6) 3.5 (2.6-3.9) 1.9 (3.2-1.9) 2.2 (1. Normally distributed parameters were expressed as mean ± SD, whereas non-normally distributed parameters were expressed as median (interquartile range).
were also higher in MetS and MetS+ELAM compared with Lean (0.7 ± 0.05 and 0.7 ± 0.05 versus 0.4 ± 0.09 U ml −1 , respectively, both P < 0.05), as were HOMA-IR levels (1.8 ± 0.15 and 1.7 ± 0.34 versus 0.6 ± 0.07, respectively, both P < 0.05). In contrast, fasting glucose concentrations were similar among Lean, MetS and MetS+ELAM (129.8 ± 36.5, 117.2 ± 18.1 and 116.7 ± 32.7 mg dl −1 , respectively, all P > 0.05), as were plasma renin activity, serum creatinine, and cortical and medullary perfusion (Table 1) . Renal volume was elevated to a similar extent in MetS and MetS+ELAM compared with Lean, whereas cortical and medullary perfusion did not differ among the groups. Basal RBF and GFR were elevated to a similar extent in MetS and MetS+ELAM compared with Lean, whereas a significant increase in RBF in response to ACh was similar among the groups.
Elamipretide preserves PTC-EC mitochondria
Electron microscopy revealed that the number of PTC-EC mitochondria was markedly lower in MetS compared with Lean, but normalized in MetS+ELAM (Figure 2a ). Although PTC-EC mitochondrial area did not differ among the groups, the matrix density, which decreased in MetS, improved in ELAM-treated pigs.
Likewise, EC cardiolipin content decreased in MetS compared
with Lean, but was fully restored to normal levels in MetS+ELAM (Figure 2b ).
Mitoprotection attenuates PTC-EC damage
The number of capillaries per tubule decreased in MetS compared with Lean, but improved in MetS+ELAM (Figure 2c ). The number of pLVAP/TUNEL + apoptotic and pLVAP/nitrotyrosine + cells was higher in MetS compared with Lean, but normalized in ELAM-treated pigs (Figure 3 ).
Elamipretide ameliorates MetS-induced renal microvascular remodelling
The spatial density of cortical microvessels substantially decreased in
MetS, but improved in ELAM-treated pigs (Figure 4a ). Furthermore, medullary microvascular density, which decreased in MetS, normalized in MetS+ELAM. Vessel tortuosity, which reflects vascular immaturity, was greater in MetS compared with Lean, but restored to normal levels in ELAM-treated pigs (Figure 4b ). Vessel wall-to-lumen ratio, which was higher in MetS compared with Lean, also decreased in MetS+ELAM (Figure 4c ).
Elamipretide attenuates renal inflammation
Renal vein concentrations of IL-1 and TNF-were higher in the MetS groups compared with Lean, but decreased in ELAM-treated pigs, whereas elevated renal vein concentrations of IL-6 remained unaltered in MetS+ELAM. Tubulointerstitial fibrosis did not differ among the groups.
Elamipretide improves renal artery endothelial function
The vasorelaxation response to ACh in excised renal artery rings was impaired in MetS compared with Lean, but normalized in MetS+ELAM, whereas the response to SNP was unchanged. Cardiolipin content in renal artery sections was decreased in MetS, but restored in MetS-ELAM, as was eNOS immunoreactivity. The number of apoptotic cells (TUNEL) in renal artery rings increased in MetS, but decreased in MetS+ELAM, associated with decreased production of superoxide anion (DHE).
Elamipretide does not affect renal function in lean animals
Blood pressure, lipid fractions, serum creatinine, and plasma renin activity were similar between Lean and Lean+ELAM (Table 1) .
Likewise, renal volume, cortical and medullary perfusion, GFR,
RBF, and RBF responses to Ach did not differ between Lean and
Lean+ELAM. In addition, the vasorelaxation response to ACh and SNP in excised renal artery rings was similar in Lean and Lean+ELAM, as were cardiolipin and eNOS expression, apoptosis, and production of superoxide anion.
DISCUSSION
The The prevalence of MetS has been on the rise over the last couple of decades, increasing the risk of CKD and end-stage renal disease (Ferraro et al., 2011) . Previous studies have shown that MetS damages the renal circulation. For example, obesity in mice is associated with enhanced vascular contractility in response to angiotensin II (Barton et al., 2000) and increased responsiveness to vasoconstrictor peptides (Baretella, Chung, Barton, Xu, & Vanhoutte, 2014) . Haematoxylin-and Eosin-stained kidney sections (×40 images). The number of capillaries per tubule decreased in MetS compared with Lean, but improved in MetS+ELAM (n = 6 per group). * P < 0.05 versus Lean; † P < 0.05 versus MetS+ELAM microvascular loss . Importantly, dysfunctional or damaged vessels can progressively impair renal perfusion, filtration and tubular function (Chade, 2013) , underscoring the need to design new therapies to protect the renal vasculature in patients with
MetS.
The present study extends our previous observations on renovascular disease (Eirin et al., 2012b , demonstrating . The number of PTC-ECs (pLVAP; green) positive for TUNEL (red) was elevated in MetS, but decreased to normal levels in MetS+ELAM (n = 6 per group). Treatment with ELAM restored double immunoreactivity of nitrotyrosine (red) and pLVAP (n = 6 per group). * P < 0.05 versus Lean; † P < 0.05 versus MetS + ELAM rarefaction predicts interstitial damage and renal functional decline in patients with CKD (Kida, Tchao, & Yamaguchi, 2014) . In the present study, improvement of the number of PTCs by ELAM was associated with restoration of EC cardiolipin content, mitochondrial number and matrix density, underscoring the role of mitochondria in regulating the PTC circulation in experimental MetS.
Capillary rarefaction results from an interplay among several pathogenic mechanisms, including apoptosis, oxidative stress and reduced availability of vasoactive substances. Peritubular capillary ECs undergoing apoptosis have increased pro-coagulant and proadhesive properties, contributing to capillary occlusion, thrombosis and inflammation, ultimately exacerbating PTC loss (Winn & Harlan, 2005) . Oxidative stress-induced PTC-EC obliteration reduces PTC flow, inducing tubular ischaemic injury and tubulointerstitial fibrosis (Futrakul et al., 2002) . Interestingly, the present study shows that treatment with ELAM attenuated PTC-EC oxidative stress and apoptosis, possibly by preventing release of pro-oxidant and proapoptotic factors into the cytosol. Therefore, these observations support a direct effect of mitochondrial protection to ameliorate MetSinduced PTC-EC apoptosis and oxidative stress.
Elamipretide also improved the larger renal microvessels, a network of medium-sized cortical and medullary vessels that envelops each nephron. We and others have shown that microvascular remodelling and loss are correlated with progressive deterioration of renal perfusion and tubular function and are important determinants of renal dysfunction (Eirin et al., 2010; Iliescu, Fernandez, Kelsen, Maric, & Chade, 2010) . In the present study, we found that loss of cortical and medullary microvessels was substantially improved in MetS+ELAM pigs, resembling our previous observations in renovascular disease (Eirin et al., 2012b . Likewise, ELAM attenuated microvascular remodelling, reflected by the decrease in vessel tortuosity and mediato-lumen ratio, uncovering its potential to preserve the renal microvasculature in MetS.
Preservation of intrarenal PTCs and microvessels in ELAM-treated (b) Vessel tortuosity was higher in MetS, but normalized in ELAM-treated pigs (n = 6 per group). (c) Renal vessel wall-to-lumen ratio in -smooth muscle actin-stained slides. Vessel wall-to-lumen ratio, which was higher in MetS compared with Lean, improved in ELAM-treated pigs (n = 6 per group). * P < 0.05 versus Lean; † P < 0.05 versus MetS+ELAM staining. In contrast, the RBF response to ACh, reflecting endotheliumdependent microvascular reactivity in small vessels, was significant in all groups compared with baseline, suggesting that MetS-induced endothelial dysfunction is more pronounced in large vessels. In summary, our study shows that mitoprotection with ELAM preserved mitochondrial density and cardiolipin content and improved both the structure and the function of the renal circulation. At the level of capillaries, ELAM increased the number of PTC-ECs and attenuated their oxidative stress and apoptosis. In larger renal microvessels, ELAM attenuated remodelling and loss, whereas in renal artery segments it improved endothelium-dependent relaxation. Therefore, our observations are consistent with the notion that MetS-induced mitochondrial alterations might impair small, medium and large renal vessels and suggest a potential role for mitoprotection in ameliorating renal vascular injury in MetS. Further studies are needed to determine the long-term effect of ELAM and to establish its vasculoprotective properties in patients with MetS.
